Lamont EB[Author] - Search Results

Year	Number of Results
1997	1
1999	3
2000	3
2001	2
2002	3
2003	4
2004	1
2005	2
2006	3
2007	2
2008	4
2009	4
2010	4
2011	4
2012	10
2013	3
2014	5
2015	2
2016	2
2017	2
2021	2
2022	0

1

Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic.

Lamont EB, Diamond SS, Katriel RG, Ensign LL, Liu J, Rusli E, Alexander GC. Lamont EB, et al. JAMA Netw Open. 2021 Jan 4;4(1):e2036353. doi: 10.1001/jamanetworkopen.2020.36353. JAMA Netw Open. 2021. PMID: 33502481 Free PMC article.

2

The oral fluoropyrimidines in cancer chemotherapy.

Lamont EB, Schilsky RL. Lamont EB, et al. Clin Cancer Res. 1999 Sep;5(9):2289-96. Clin Cancer Res. 1999. PMID: 10499595 Review.

3

Associations Between Amplification (1q) and Prior Cancer in a Real-World De Novo Myeloma Cohort.

Lamont EB, Yee AJ, Goldberg SL, Siegel DS, Norden AD. Lamont EB, et al. JNCI Cancer Spectr. 2021 Jan 4;5(1):pkaa111. doi: 10.1093/jncics/pkaa111. eCollection 2021 Feb. JNCI Cancer Spectr. 2021. PMID: 33442665 Free PMC article.

4

Rural residence and cancer outcomes in the United States: issues and challenges.

Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB. Meilleur A, et al. Among authors: lamont eb. Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1657-67. doi: 10.1158/1055-9965.EPI-13-0404. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24097195 Free PMC article. Review.

5

Some elements of prognosis in terminal cancer.

Lamont EB, Christakis NA. Lamont EB, et al. Oncology (Williston Park). 1999 Aug;13(8):1165-70; discussion 1172-4, 1179-80. Oncology (Williston Park). 1999. PMID: 10499248 Free article. Review.

6

Use of High-cost Systemic Treatments in Elderly mCRC Patients.

Bradley CJ, Yabroff KR, Warren JL, Zeruto C, Chawla N, Lamont EB. Bradley CJ, et al. Among authors: lamont eb. Med Care. 2017 Jan;55(1):86-87. doi: 10.1097/MLR.0000000000000612. Med Care. 2017. PMID: 27547951 Free PMC article. No abstract available.

7

A demographic and prognostic approach to defining the end of life.

Lamont EB. Lamont EB. J Palliat Med. 2005;8 Suppl 1:S12-21. doi: 10.1089/jpm.2005.8.s-12. J Palliat Med. 2005. PMID: 16499460 Review.

8

Chemotherapy in the management of squamous-cell carcinoma of the head and neck.

Lamont EB, Vokes EE. Lamont EB, et al. Lancet Oncol. 2001 May;2(5):261-9. doi: 10.1016/S1470-2045(00)00320-X. Lancet Oncol. 2001. PMID: 11905780 Review.

9

Genotyping lung cancer is an investment in the future.

Azzoli CG, Engelman J, Fidias P, Gainor JF, Heist RS, Lamont EB, Lennes IT, Rosovsky RP, Sequist LV, Shaw AT, Temel JS. Azzoli CG, et al. Among authors: lamont eb. J Clin Oncol. 2014 Nov 1;32(31):3576-7. doi: 10.1200/JCO.2014.56.6430. Epub 2014 Sep 8. J Clin Oncol. 2014. PMID: 25199750 No abstract available.

10

Tumor boards and the quality of cancer care.

Keating NL, Landrum MB, Lamont EB, Bozeman SR, Shulman LN, McNeil BJ. Keating NL, et al. Among authors: lamont eb. J Natl Cancer Inst. 2013 Jan 16;105(2):113-21. doi: 10.1093/jnci/djs502. Epub 2012 Dec 28. J Natl Cancer Inst. 2013. PMID: 23274388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results